Published in Obesity and Diabetes Week, April 12th, 2004
Dr. Morton joins Paradigm Genetics' board as part of the company's recently completed acquisition of TissueInformatics.Inc.
"With Doug, we gain exceptional perspective and leadership from a seasoned pharmaceutical executive with a highly productive and diverse career," said Heinrich Gugger, PhD, president and chief executive officer of Paradigm Genetics.
"His appointment reflects the rapid evolution of our...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.